| Pre- and postprocedure | Preprocedure only | Postprocedure only | No interruption | Total |
---|
Major surgerya, b | 160 (58.4) | 47 (17.2) | 13 (4.7) | 54 (19.7) | 274 (100) |
Nonmajor surgeryc | 114 (22.3) | 222 (43.4) | 16 (3.1) | 160 (31.3) | 512 (100) |
High risk | 6 (46.2) | 4 (30.8) | 0 | 3 (23.1) | 13 (100) |
Low risk | 38 (20.3) | 70 (37.4) | 6 (3.2) | 73 (39.0) | 187 (100) |
Minor risk | 69 (22.2) | 148 (47.6) | 10 (3.2) | 84 (27.0) | 311 (100) |
Unknown | 1 (100) | 0 | 0 | 0 | 1 (100) |
- Data are shown as n (%)d
- High-risk nonmajor surgeries include orthopaedic (hand surgery; n = 4), gastroenterology (tumour excision; n = 5); cardiothoracic and vascular (thoracotomy/thoracocentesis ± chest tubes; n = 3), and general surgery (solid organ resection; n = 1)
- EHRA European Heart Rhythm Association, n Number of surgeries
- aMedian edoxaban interruption time for major surgeries was 4.0 days
- bFor 2 surgeries, data for edoxaban use on the date of the surgery are unavailable
- cMedian edoxaban interruption time for nonmajor surgeries was 1.0 day
- dPercentages are relative to the total number of surgeries in each surgery group